A study showed that CBD endocannabinoid decreases breast cancer aggressiveness by downregulating the helix–loop–helix protein Id-1, an inhibitor of basic helix–loop–helix transcription factors that promote human breast cancer progression [20]. This evidence concerns the gene ID1 and breast cancer.